From: The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
Clinicopathological parameters | t value | df | P value |
---|---|---|---|
Tumor differentiation | 1.78 | 12 | 0.484 |
Tumor TNM stage | 1.08 | 16 | 0.714 |
Primary residual tumor | 0.66 | 3 | 0.997 |
Response to chemotherapy | 3.42 | 3 | 0.174 |
Age | 6.15 | 4 | 0.142 |
Lymphatic metastasis | 2.97 | 5 | 0.243 |
Histology | 0.66 | 8 | 0.322 |
Ascites | 0.67 | 4 | 0.327 |
Overall survival | 2.26 | 11 | 0.531 |
Disease free survival | 0.21 | 4 | 1.000 |